Medtronic gets FDA approval for BrainSense device in Parkinson's patients

In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain. On Monday, the Fridley-run company announced the regulatory win for its BrainSense Adaptive deep brain stimulation in a thin, surgically-implanted neurostimulator in the chest with leads stretching through the neck to the bra…

Medtronic gets FDA approval for BrainSense device in Parkinson's patients

Medtronic said Monday the U.S. Food and Drug Administration has approved a brain stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology.

FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease

(MedPage Today) -- The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like other DBS devices, the newly...

Parkinson’s Patients Now Have a New Way to Manage Symptoms

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is programmed to respond to and manage abnormal brain signals that contribu…

FDA approves first adaptive deep brain stimulation system for Parkinson’s

Real-time neuromodulation offers more precise treatment for Parkinson’s patients.

FDA Approves Personalized Brain Stimulation Device for Parkinson’s

Medtronic has announced FDA approval of BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s. “Medtronic is the only company in the world to offer an adaptive DBS system that dynamically adjusts therapy in real time,” said Brett Wall, executive vice president and president of the Medtronic Neuroscience Portfolio. He added, “This new era in Parkinson’s care represents more than a…